ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 755427 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 755427; 2) Community: the network communities that were significantly associated with the response to NSC 755427; 3) Molecule: the relationships between components within communities and NSC 755427; 4) MDR: the compounds that were significantly associated with the NSC 755427.

NSC Compound Enrichment Correlation
NSC 107124 Camptothecin Derivative 0.0267520285931239 0.27928576
NSC 129518 Cyclopyrethrosin 0.0267520285931239 0.26372473
NSC 13477 Null 0.0267520285931239 0.14283198
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.0267520285931239 0.43385245
NSC 179940 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0267520285931239 0.55031386
NSC 255111 19-Formylgeldanamycin N-piperidinoimine 0.0267520285931239 0.27011208
NSC 269756 Baccharinol B4 0.0267520285931239 0.052043029
NSC 282159 EN 589 0.0267520285931239 0.2752973
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.0267520285931239 0.47573707
NSC 305799 2,4-Quinazolinediamine, 6-[[4-(dimethylamino)phenyl]thio]- 0.0267520285931239 0.5761821
Total:132  Current:84    [First] [Prev] [Next] [Last]